John Park, MD, PhD, has joined the faculty of Weill Cornell Medicine as Chief of Neurological Surgery at NewYork-Presbyterian Queens, continuing the rapid growth of advanced specialty service available there. With this appointment, Dr. Park takes on the leadership of a neurosurgical team that provides world-class care for all conditions of the brain and spine to more than 2.3 million residents of Queens.
“I am proud to have recruited Dr. Park to return to his roots in Queens,” says Dr. Philip E. Stieg, Neurosurgeon-in-Chief of NewYork-Presbyterian Weill Cornell Medicine. “We are committed to bringing the very best in care to the boroughs so patients can find the experts they need right in their own neighborhoods. Dr. Park has twenty years of experience in the neurosurgical treatment of brain and spine conditions, and we are lucky to have brought him back here to provide that expertise to our patients in Queens.”
“Competition for neuroscience growth continues to intensify in Queens,” says Dr. Amir Jaffer, Chief Medical Officer of New-York Presbyterian Queens. “Having a leader like Dr. Park with both a strong academic background and experience of having grown a community neurosurgery program will be instrumental in further strengthening the referral relationship, developing a comprehensive spine program, and further transforming stroke management in collaboration with Neurology”.
Since the former New York Hospital Queens became part of the NewYork-Presbyterian system in 2015, the neurosurgical team there has grown to include cerebrovascular specialist Ning Lin, MD; interventional neuroradiologist Srikanth Boddu, MD; and brain tumor specialist Rupa Juthani, MD. The team, now led by Dr. Park, who has particular expertise in the treatment of brain and spinal tumors and degenerative disorders of the cervical and lumbar spine, provides the full range of treatment for neurosurgical conditions.
Before joining the faculty at the Weill Cornell Brain and Spine Center, Dr. Park founded and served as the medical director of the multidisciplinary Brain and Spinal Tumor Program at Cottage Health in Santa Barbara. Prior to that, at the National Institutes of Health Clinical Center in Bethesda, Maryland, Dr. Park developed a national reputation for the surgical treatment of low-grade gliomas and recurrent malignant gliomas and served as the principal neurosurgeon for patients enrolled in NCI clinical trials for malignant gliomas.
Dr. Park earned his MD and PhD degrees at Harvard Medical School, then completed his residency training in neurosurgery at Harvard at Brigham and Women’s Hospital and Children’s Hospital. He completed a research fellowship at Dana Farber Cancer Institute and received advanced spine training at Cleveland Clinic.
